Search Results - "Qiu, Yongle"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1 by Liu, Daxiang, Wang, Wenjing, Wu, Yanzhao, Qiu, Yongle, Zhang, Lan

    Published in Current cancer drug targets (01-01-2024)
    “…Medullary thyroid carcinoma (MTC) is a rare but aggressive endocrine malignancy that originates from the parafollicular C cells of the thyroid gland. Enhancer…”
    Get more information
    Journal Article
  2. 2

    Biomimetic Nanosystems for the Synergistic Delivery of miR-144/451a for Oral Squamous Cell Carcinoma by Li, Kunshan, Qiu, Yongle, Liu, Xin, Huang, Fang

    Published in Balkan medical journal (24-05-2022)
    “…The miR-144/451a cluster acts as a tumor suppressor in various tumors by synergistically inhibiting the proliferation, migration, and invasion of oral squamous…”
    Get full text
    Journal Article
  3. 3

    Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma by Qiu, Yongle, Sun, Jieming, Qiu, Junping, Chen, Guoling, Wang, Xiao, Mu, Yaxu, Li, Kunshan, Wang, Wenjing

    Published in Cancer management and research (01-01-2020)
    “…TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) can induce apoptosis in a variety of cancer cells. However, drug resistance of tumor and short…”
    Get full text
    Journal Article
  4. 4

    Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3 by Hu, Yan, Lv, Feifei, Li, Na, Yuan, Xuewei, Zhang, Liru, Zhao, Shuangling, Jin, Linyu, Qiu, Yongle

    Published in FEBS open bio (01-01-2023)
    “…Oral squamous cell carcinoma (OSCC) accounts for about 90% of oral cancers. Expression of the long noncoding RNA (lncRNA) maternally expressed 3 (MEG3) has…”
    Get full text
    Journal Article
  5. 5

    Screening and cellular validation of prognostic genes regulated by super enhancers in oral squamous cell carcinoma by Zhang, Liru, Li, Huanju, Qiu, Yongle, Liu, Yuanhang, Liu, Xin, Wang, Wenjing

    Published in Bioengineered (20-12-2021)
    “…Oral squamous cell carcinoma (OSCC) is the leading cause of death in patients with head and neck cancer. Reliable biomarkers to guide treatment decisions for…”
    Get full text
    Journal Article
  6. 6

    HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas by Na, Li, Meijie, Zhang, Wenjing, Zhai, Bing, Zhou, Yanhao, Duan, Shanshan, Liu, Yongle, Qiu

    Published in BMC oral health (05-11-2022)
    “…Abstract Background Oral squamous cell carcinoma (OSCC) is the main type of oral cancer. Disturbing DNA repair is an invaluable way to improve the…”
    Get full text
    Journal Article
  7. 7

    MicroRNA‐218 inhibits type I interferon production and facilitates virus immune evasion via targeting RIG‐I by Qiu, Yongle, Geng, Xixue, Ban, Jiandong, Liu, Yuanhang

    Published in Biotechnology and applied biochemistry (01-05-2020)
    “…The host protective immunity against viral infection requires the effective detection of viral antigens and the subsequent production of type I interferons…”
    Get full text
    Journal Article
  8. 8

    hsa‑miR‑216a‑3p regulates cell proliferation in oral cancer via the Wnt3a/β‑catenin pathway by Wang, Yifan, Liu, Shanshan, Lv, Feifei, Zhai, Wenjing, Wang, Weina, Duan, Yanhao, Qiu, Yongle

    Published in Molecular medicine reports (01-06-2023)
    “…Oral cancer is one of the leading causes of death worldwide, with a reported 5‑year survival rate of ~50% after treatment. The treatment measures for oral…”
    Get full text
    Journal Article
  9. 9

    hsa-miR-216a-3p regulates cell proliferation in oral cancer via the Wnt3a/[beta]-catenin pathway by Wang, Yifan, Liu, Shanshan, Lv, Feifei, Zhai, Wenjing, Wang, Weina, Duan, Yanhao, Qiu, Yongle

    Published in Molecular medicine reports (01-06-2023)
    “…Oral cancer is one of the leading causes of death worldwide, with a reported 5-year survival rate of ~50% after treatment. The treatment measures for oral…”
    Get full text
    Journal Article
  10. 10

    Maternally expressed 3 inhibits the biological activity of oral squamous cell carcinoma SCC25 and CAL27 cell lines by Wang, Wenjing, Li, Huanju, Qiu, Yongle, Li, Kunshan, Lu, Yueting, Deng, Qianlan, Liu, Tiejun

    Published in Oncology letters (01-11-2021)
    “…The abnormal expression of long non-coding RNA (lncRNA) maternally expressed 3 (MEG3) is closely related to several tumor diagnosis and progression, such as…”
    Get full text
    Journal Article